Preclinical News and Research

RSS
Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

MicroRNA biomarker shows promise in predicting treatment response of ovarian cancer

MicroRNA biomarker shows promise in predicting treatment response of ovarian cancer

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Professor receives ALSF grant to develop cancer vaccine technology that help children to have healthy life

Professor receives ALSF grant to develop cancer vaccine technology that help children to have healthy life

Biothera reports positive results from Phase 2 clinical trial of Imprime PGG in NSCLC patients

Biothera reports positive results from Phase 2 clinical trial of Imprime PGG in NSCLC patients

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

Adocia initiates phase IIa clinical trial of BioChaperone Lispro formulation

Adocia initiates phase IIa clinical trial of BioChaperone Lispro formulation

USAMRMC to develop strategic research plan that identifies critical research priority areas in TBI

USAMRMC to develop strategic research plan that identifies critical research priority areas in TBI

Portage acquires approximately 54% equity in Biohaven

Portage acquires approximately 54% equity in Biohaven

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Cerenis' Phase IIb CHI-SQUARE study fails to meet primary endpoint in post-ACS patients

Cerenis' Phase IIb CHI-SQUARE study fails to meet primary endpoint in post-ACS patients

Oral ingestion of inosine compound raises urate levels, shows Parkinson's study

Oral ingestion of inosine compound raises urate levels, shows Parkinson's study

Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering

Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

TSRI scientists identify compound that shows promise for treating obesity-linked diabetes

TSRI scientists identify compound that shows promise for treating obesity-linked diabetes

CUMC researchers clarify three fundamental issues about Alzheimer's disease

CUMC researchers clarify three fundamental issues about Alzheimer's disease

ORIX USA Health partners with TGen and TD2 to support Arizona's biomedical economy

ORIX USA Health partners with TGen and TD2 to support Arizona's biomedical economy

Study reveals that global pricing teams outsource 50% of activities

Study reveals that global pricing teams outsource 50% of activities

New research assesses nanomedicine-based approaches for treating cancer

New research assesses nanomedicine-based approaches for treating cancer

Merck and CNIO sign agreement to collaborate in area of cancer drug development

Merck and CNIO sign agreement to collaborate in area of cancer drug development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.